The company's laboratory-developed test (LDT) for neurofilament light chain (NfL) also gained New York State approval as part of the permitting process.

The program offers lower-cost, refurbished testing instruments as well as customer education, inventory management, and enhanced service agreements.

Financial and other terms of the deal were not disclosed.

The all-virtual program is currently looking for a second cohort of novel diagnostics technologies, with a Sept. 30 deadline for new applications.

According to a company executive, the transactions will provide QuidelOrtho with greater financial flexibility while funding its continued growth.

NEW YORK — The Scottish government has earmarked £800,000 ($1.1 million) to support the introduction of a Genedrive test to help prevent antibiotic-induced deafness in newborns within the country, ...

Reviewers winnowed an initial 27 assays to a group of nine that were evaluated using NCI sample sets, ultimately choosing ClearNote's Avantect and Guardant's Shield.

UCLA's Electric Field-Induced Release and Measurement (EFIRM) system could offer the early detection of cancers and other diseases through a droplet-size saliva sample.

TBI is a potential new application area for the 8-year-old company, while it continues to commercialize its stroke triage ...

The organization noted that US senators have introduced a bill to accelerate Medicare coverage for breakthrough devices.

The MMR IHC Panel PharmaDx (Dako Omnis) is used to identify loss of function in mismatch repair proteins and inform the treatment of colorectal cancer patients.

Ospri specializes in PCR-based infectious disease detection and is financed by up to $30 million of strategic funding from Catalio Capital Management.